[1]
Xueqin Zhu, Yang Liu, Jiao Guo, Junyuan Cao, Zonglin Wang, Gengfu Xiao, Wei Wang, 2021: Effects of N-Linked Glycan on Lassa Virus Envelope Glycoprotein Cleavage, Infectivity, and Immune Response, Virologica Sinica, 36, 774-783. doi: 10.1007/s12250-021-00358-y
[2]
徐凌云, 赵文彬, 扬永钦, 鞠海, 邹霖, 张学凯, 刘光中, 1990: The Immune Response of Hepatitis B Vaccine Combined with BCG DPT and TOPV, Virologica Sinica, 5, 30-.
[3]
Farahnaz Motamedi Sedeh, Hoorieh Soleimanjahi, AmirReza Jalilian, Homayoon Mahravani, 2012: Comparison of Immune Responses against FMD by a DNA Vaccine Encoding the FMDV/O/IRN/2007 VP1 Gene and the Conventional Inactivated Vaccine in an Animal Model, Virologica Sinica, 27, 286-291. doi: 10.1007/s12250-012-3258-5
[4]
邵先安, 沈燕, 徐薇, 王缨, 胡新美, 熊思东*, 2004: Immunological Characteristics of a 27kDa Protein in the Bovine Sera, Virologica Sinica, 19, 6-9.
[5]
方肇寅, 温乐英, R.Glass, 1993: Western Blot Analysis of Viral Proteins Of Adult Diarrhea Rotavirus, Virologica Sinica, 8, 235-242.
[6]
Jia Liu, Anna Kosinska, Mengji Lu, Michael Roggendorf, 2014: New therapeutic vaccination strategies for the treatment of chronic hepatitis B, Virologica Sinica, 29, 10-16. doi: 10.1007/s12250-014-3410-5
[7]
黄重敏*, 覃亚勤, 覃后继, 卢东, 何延专, 覃雪英, 2004: Study on Hepatitis B Virus Genotypes in Groups of the Zhuang Nationality in Western Guangxi, Virologica Sinica, 19, 177-178.
[8]
Yan-bin Ma, Hui-yun Chang, 2011: Caspase Work Model During Pathogen Infection ^*, Virologica Sinica, 26, 366-375. doi: 10.1007/s12250-011-3218-5
[9]
Inderdeep Kaur, C Gupta R, Puri Munish, 2011: Ribosome Inactivating Proteins from Plants Inhibiting Viruses ^*, Virologica Sinica, 26, 357-365. doi: 10.1007/s12250-011-3223-8
[10]
TIAN Hong, WU Jing-yan, SHANG You-jun, YING Shuang-hui, ZHENG Hai-xue, LIU Xiang-tao, 2010: Expression and Immunological Analysis of Capsid Protein Precursor of Swine Vesicular Disease Virus HK/70, Virologica Sinica, 25, 206-212. doi: 10.1007/s12250-010-3100-x
[11]
张彩红, 姜秀丽, 王敏, 张彦明, 王健伟, 洪涛, 2005: Immune Response Induced by Recombinant Adenoviruses Expressing Serotype G2 or G3 VP7 of Group A Human Rotavirus in Mice, Virologica Sinica, 20, 352-356.
[12]
吴娟, 李嘉琦, 孙茂盛, 戴长柏, 2002: The Immune Response Induced by Recombinant Adenovirus with Administration of Interaperitonea Injection, Virologica Sinica, 17, 51-55.
[13]
房德兴, 甘人宝, 李载平, 翟春生, 周宗安, 1999: Different Nueleotide Sequences within One of Hepatitis B Virus Clones Patient, Virologica Sinica, 14, 52-57.
[14]
He-bin FAN, Bao-ju WANG, Yin-ping LU, You-hua HAO, Xin-xing YANG, Meng-ji LU, Dong-liang YANG, 2008: Silencing of UBP43 by shRNA Enhances the Antiviral Activity of Interferon against Hepatitis B Virus^*, Virologica Sinica, 23, 339-344. doi: 10.1007/s12250-008-2960-9
[15]
Wei LI, Yuan-ying SHEN, Xuan-rong ZHANG, Lai-feng REN, Qiang LI, Ru SHEN, Hai-ping ZHAO, 2008: Research on Hepatitis B virus Genotypes and Subgenotypes among Bai Nationality in Dali, Yunnan Province, Virologica Sinica, 23, 57-62. doi: 10.1007/s12250-008-2923-1
[16]
房德兴, 周宗安, 翟春生, 顾志香, 王元伦, 何亮, 1998: High-level expression of hepatitis B virus adr subtype X protein in Escherichia coli, Virologica Sinica, 13, 122-.
[17]
胡克勤, 喻植群, 张永源, 李方和, 郝连杰, 1989: Researches on Pre-S Proteins of Hepatitis B Virus Ⅵ. Binding of Pre-S Proteins with Human Serum Albumin, Virologica Sinica, 4, 159-.
[18]
Ju-sheng LIN, Lin-lin GAO, 2008: Advances in Research on Hepatitis B Virus DNA Integration, Virologica Sinica, 23, 93-99. doi: 10.1007/s12250-008-2939-6
[19]
Yin-ping LU, Bao-ju WANG, Ji-hua DONG, Zhao LIU, Shi-he GUAN, Meng-ji LU, Dong-liang YANG, 2007: Construction and Characterization of a Hepatitis B Virus Replicon, Virologica Sinica, 22, 8-13.
[20]
严亚琼, 陈冬峨, 曾艳彩, , , , 2004: Study on Risk Relationship between Hepatitis B Virus and Primary Hepatocellular Carcinoma, Virologica Sinica, 19, 549-552.